4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-24-000026
CFO & Chief Business Officer sold 4,242 shares at $3.71 ($15,717)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zuga Matt CFO & Chief Business Officer | 2024-01-18 | Sale 10b5-1 | −4,242 | $3.71 | $15,717 | 211,445 | D |
| Open-market sales · 4,242 sh · avg $3.71 · $15,717 | |||||||
Loading xslF345X05/wk-form4_1705709143.xml…